Synergy Pharmaceuticals Company Profile (NASDAQ:SGYP)

About Synergy Pharmaceuticals

Synergy Pharmaceuticals logoSynergy Pharmaceuticals Inc. (Synergy) is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. The Company's GI platform includes two lead product candidates: plecanatide and dolcanatide. It is engaged in the discovery, research and development involving uroguanylin analogs for the treatment of functional GI disorders and inflammatory bowel disease. Plecanatide is the Company's uroguanylin analog being evaluated for use as a once-daily tablet for two functional GI disorders, chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Plecanatide is a 16-amino acid peptide that is structurally identical to uroguanylin with the exception of a single amino acid change. Dolcanatide is also its uroguanylin analog being explored for inflammatory bowel disease (IBD). Dolcanatide is designed to be an analog of uroguanylin with resistance to standard digestive breakdown by proteases in the intestine.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: SGYP
  • CUSIP: 87163930
Key Metrics:
  • Previous Close: $5.26
  • 50 Day Moving Average: $5.35
  • 200 Day Moving Average: $4.19
  • 52-Week Range: $2.50 - $7.15
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -13.84
  • P/E Growth: 0.00
  • Market Cap: $943.89M
  • Outstanding Shares: 179,446,000
  • Beta: 745.59
  • Return on Assets: -104.56%
  • Debt-to-Equity Ratio: 1.60%
  • Current Ratio: 6.29%
  • Quick Ratio: 6.29%
Additional Links:
Companies Related to Synergy Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Synergy Pharmaceuticals (NASDAQ:SGYP) (?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $10.75 (104.37% upside)

Analysts' Ratings History for Synergy Pharmaceuticals (NASDAQ:SGYP)
DateFirmActionRatingPrice TargetDetails
10/21/2016Canaccord GenuityReiterated RatingBuy$13.00View Rating Details
10/17/2016BTIG ResearchReiterated RatingPositive$11.00View Rating Details
9/8/2016HC WainwrightSet Price TargetBuy$15.00View Rating Details
9/8/2016Rodman & RenshawReiterated RatingBuy$15.00View Rating Details
5/26/2016Roth CapitalReiterated RatingBuy$6.50View Rating Details
3/16/2016Citigroup Inc.Lower Price TargetNeutral$7.00 -> $4.00View Rating Details
6/18/2015Cantor FitzgeraldReiterated RatingBuy$8.50 -> $14.00View Rating Details
(Data available from 10/25/2014 forward)


Earnings History for Synergy Pharmaceuticals (NASDAQ:SGYP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2016Q216($0.20)($0.23)ViewN/AView Earnings Details
5/10/2016Q1($0.23)($0.51)ViewN/AView Earnings Details
11/9/2015Q315($0.28)($0.23)ViewN/AView Earnings Details
8/10/2015Q215($0.28)($0.34)$102.00 millionViewN/AView Earnings Details
5/11/2015Q115($0.33)($0.28)ViewN/AView Earnings Details
3/16/2015($0.28)($0.32)ViewN/AView Earnings Details
11/10/2014($0.28)($0.24)ViewN/AView Earnings Details
8/11/2014($0.23)($0.28)ViewN/AView Earnings Details
5/13/2014Q114($0.23)($0.18)ViewN/AView Earnings Details
3/17/2014Q4 13($0.20)($0.22)ViewN/AView Earnings Details
11/12/2013Q3($0.17)($0.15)ViewN/AView Earnings Details
11/13/2012Q312($0.01)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Synergy Pharmaceuticals (NASDAQ:SGYP)
Current Year EPS Consensus Estimate: $-0.83 EPS
Next Year EPS Consensus Estimate: $-0.38 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.19)($0.19)($0.19)
Q2 20161($0.25)($0.25)($0.25)
Q3 20161($0.25)($0.25)($0.25)
Q4 20161($0.18)($0.18)($0.18)
(Data provided by Zacks Investment Research)


Dividend History for Synergy Pharmaceuticals (NASDAQ:SGYP)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Synergy Pharmaceuticals (NASDAQ:SGYP)
Insider Ownership Percentage: 3.60%
Institutional Ownership Percentage: 56.54%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/28/2016Paulson & Co. Inc.Major ShareholderSell54,300$5.69$308,967.00View SEC Filing  
9/19/2016John P BrancaccioDirectorSell2,518$5.76$14,503.68View SEC Filing  
9/19/2016Paulson & Co. Inc.Major ShareholderSell3,473,713$5.61$19,487,529.93View SEC Filing  
9/14/2015Bernard DenoyerSVPSell10,000$7.50$75,000.00View SEC Filing  
9/11/2015Alan JoslynDirectorSell13,754$7.22$99,303.88View SEC Filing  
6/3/2014John P BrancaccioDirectorBuy3,500$4.12$14,420.00View SEC Filing  
5/27/2014Gary S JacobCEOBuy4,000$4.18$16,720.00View SEC Filing  
5/23/2014Bernard DenoyerSVPBuy2,500$3.89$9,725.00View SEC Filing  
5/23/2014Kunwar ShailubhaiInsiderBuy3,000$3.89$11,670.00View SEC Filing  
10/29/2013Gabriel CerroneDirectorBuy12,000$4.09$49,080.00View SEC Filing  
6/21/2013Bernard DenoyerSVPBuy7,500$4.78$35,850.00View SEC Filing  
6/14/2013Gabriel CerroneChairmanBuy8,000$4.42$35,360.00View SEC Filing  
4/24/2013Gabriel CerroneChairmanBuy5,500$4.66$25,630.00View SEC Filing  
2/5/2013Gabriel CerroneChairmanBuy5,000$6.15$30,750.00View SEC Filing  
2/4/2013Gabriel CerroneChairmanBuy13,090$6.04$79,063.60View SEC Filing  
1/30/2013Gabriel CerroneChairmanBuy26,000$5.98$155,480.00View SEC Filing  
11/14/2012Gabriel CerroneChairmanBuy87,820$3.61$317,030.20View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Synergy Pharmaceuticals (NASDAQ:SGYP)
DateHeadline logoPresentation at ACG Meeting Offers Insight Into Synergy Pharmaceuticals Inc's (SGYP) Plecanatide; HC Wainwright ... - Smarter Analyst (NASDAQ:SGYP) - October 24 at 6:57 PM
News Icon2 Stocks Analyst-Opinion Need Close Attention: Synergy ... - The Voice Registrar (NASDAQ:SGYP) - October 21 at 7:20 PM logoSynergy Pharma (SGYP) Announces Long-Term Plecanatide Data Update in CIC w/ IBS-C (NASDAQ:SGYP) - October 19 at 7:59 PM logoCanaccord Positive on Synergy Pharmaceuticals Inc (SGYP) Following New Long-Term Safety Data in CIC - Smarter Analyst (NASDAQ:SGYP) - October 19 at 7:59 PM logoStocks Under Consideration: The Chemours Company (CC), Synergy Pharmaceuticals, Inc. (SGYP), Campbell Soup ... - iStreetWire (NASDAQ:SGYP) - October 18 at 12:39 PM logoSynergy Pharmaceuticals Inc (SGYP) Stock Heading Upward On Data Release (NASDAQ:SGYP) - October 18 at 12:39 PM
News IconStocks Buzz: Ocwen Financial Corp. (NYSE:OCN), Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - The Newburgh Press (NASDAQ:SGYP) - October 17 at 7:09 PM logoSynergy Pharmaceuticals Inc (SGYP) Drug Plecanatide Has Multi-Million Dollar Sales Potential: BTIG - Smarter Analyst (NASDAQ:SGYP) - October 17 at 7:09 PM logoSynergy Pharmaceuticals Presents Long-Term Data for Plecanatide in Chronic Idiopathic Constipation at the American College of Gastroenterology (ACG) Annual Scientific Meeting (NASDAQ:SGYP) - October 17 at 12:33 PM
News IconUpsurge Transpiring Pre-Market for Shares of Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - CSZ News (NASDAQ:SGYP) - October 17 at 12:33 PM logoSynergy Pharma Reports Long-Term Data On Plecanatide In Chronic Idiopathic Constipatio (NASDAQ:SGYP) - October 17 at 9:49 AM logoLack of Catalysts Keeps Analysts Away From Pfizer (NASDAQ:SGYP) - October 13 at 7:28 PM
News IconFeatured Stock Overview: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - FactsReporter (NASDAQ:SGYP) - October 13 at 11:02 AM
News IconSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Insider Trading Review - Newburgh Press (NASDAQ:SGYP) - October 10 at 12:01 PM
News IconMovers to Watch: Synergy Pharmaceuticals Inc (NASDAQ:SGYP ... - NYSE Journal (press release) (NASDAQ:SGYP) - October 10 at 12:01 PM logoSynergy Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) (NASDAQ:SGYP) - October 6 at 12:52 PM logoSynergy Pharmaceuticals Getting Closer To 'Go Time' - Seeking Alpha (NASDAQ:SGYP) - October 5 at 7:08 PM
News IconInsider Trading Recap: Synergy Pharmaceuticals Inc (SGYP) - The Voice Registrar (NASDAQ:SGYP) - October 1 at 6:24 PM
News IconQuarterly EPS analysis of Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) - Newburgh Press (NASDAQ:SGYP) - September 30 at 7:36 PM logoSynergy Pharma (SGYP) Will Present New Plecanatide Data in CIC ... - (NASDAQ:SGYP) - September 29 at 12:43 PM
News IconTeva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) & Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Watch List - Money News (NASDAQ:SGYP) - September 29 at 12:43 PM logoSynergy Pharma (SGYP) Will Present New Plecanatide Data in CIC, IBS-C at ACG Meeting (NASDAQ:SGYP) - September 28 at 12:31 PM
News IconSynergy Pharmaceuticals Announces New Plecanatide Data Presentations at Upcoming Scientific Meeting & Provides Update on IBS-... (NASDAQ:SGYP) - September 28 at 12:31 PM
News IconStock's Buzz: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP), 3D Systems Corporation (NYSE:DDD) - Newburgh Press (NASDAQ:SGYP) - September 27 at 11:53 AM
News IconTwo Biotechnology Names Are Hot: UnitedHealth Group Incorporated (UNH), Synergy Pharmaceuticals, Inc. (SGYP) - The Independent Republic (NASDAQ:SGYP) - September 26 at 7:19 PM logoJohn Paulson Trims Synergy (NASDAQ:SGYP) - September 23 at 6:44 PM logoSynergy Pharmaceuticals to Present at OctoberINVESTfest 2016 (NASDAQ:SGYP) - September 23 at 11:58 AM
News IconSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Performance Analysis - Newburgh Press (NASDAQ:SGYP) - September 22 at 6:57 PM
News IconFirst Week of SGYP November 18th Options Trading (NASDAQ:SGYP) - September 20 at 12:35 PM
News IconSynergy Pharmaceuticals Inc. (NASDAQ: SGYP) Buy Rating ... - BNB Daily (blog) (NASDAQ:SGYP) - September 19 at 7:11 PM
News IconHC Stocks in the Rumor! Aerie Pharmaceuticals Inc (AERI), Synergy Pharmaceuticals Inc (NASDAQ:SGYP) - share market updates (press release) (NASDAQ:SGYP) - September 19 at 11:49 AM logoSynergy Pharmaceuticals Inc (SGYP) Has Over 97% Upside Potential; Here's Why - TCC (NASDAQ:SGYP) - September 19 at 11:49 AM logoSynergy Pharmaceuticals Inc (SGYP) Has Over 97% Upside Potential; Here's Why (NASDAQ:SGYP) - September 19 at 11:49 AM logoBTIG Bullish on Synergy Pharmaceuticals, Inc. (SGYP) Ahead of ... - Smarter Analyst (NASDAQ:SGYP) - September 17 at 11:43 AM
News IconSynergy Pharmaceuticals, Inc. (NASDAQ:SGYP) Quarterly EPS Review - Newburg Press (NASDAQ:SGYP) - September 16 at 7:01 PM
News IconVery Good Day for the Indices (NASDAQ:SGYP) - September 16 at 7:01 PM
News IconHC Stocks Reports= Synergy Pharmaceuticals Inc (SGYP), Pernix Therapeutics Holdings Inc (NASDAQ:PTX) - share market updates (press release) (NASDAQ:SGYP) - September 16 at 10:49 AM
News IconSynergy Pharmaceuticals Inc(NASDAQ:SGYP) Upward Trend - Live Trading News (NASDAQ:SGYP) - September 16 at 10:49 AM logoSynergy Pharmaceuticals Inc (SGYP) Buyout Talks Reach a Fever Pitch - (NASDAQ:SGYP) - September 16 at 10:49 AM logoSynergy Pharmaceuticals Inc (SGYP) Buyout Talks Reach a Fever Pitch (NASDAQ:SGYP) - September 15 at 1:10 PM logoNovo Nordisk A/S : Drug Makers Stocks Technical Reports -- Pernix Therapeutics, Synergy Pharma, Novo Nordisk, and Apricus Biosciences (NASDAQ:SGYP) - September 15 at 10:54 AM logoHere's a Reason Why Synergy Pharma (SGYP) Stock Is Rallying Today (NASDAQ:SGYP) - September 14 at 7:25 PM logoSynergy Pharmaceuticals, Inc. :SGYP-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016 (NASDAQ:SGYP) - September 14 at 11:39 AM logoInteresting SGYP Put And Call Options For January 2019 (NASDAQ:SGYP) - September 12 at 12:02 PM logoRodman & Renshaw Chimes in on Synergy Pharmaceuticals Inc ... - Smarter Analyst (NASDAQ:SGYP) - September 9 at 12:01 PM logoSynergy Pharmaceuticals to Present at 18th Annual Rodman & Renshaw Global Investment Conference (NASDAQ:SGYP) - September 7 at 10:57 AM
News IconSynergy Pharmaceuticals, Inc.'s (SGYP): Traders Limelight - Hot Stocks Point (NASDAQ:SGYP) - September 1 at 10:29 AM
News IconKeep an eye on Active stock of Yesterday- Synergy Pharmaceuticals, Inc.'s (SGYP) - Hot Stocks Point (NASDAQ:SGYP) - August 30 at 10:37 AM
News IconHC Stocks Highlights: Synergy Pharmaceuticals Inc (SGYP), Hologic, Inc. (HOLX) - share market updates (press release) (NASDAQ:SGYP) - August 25 at 7:36 PM
News IconSynergy Pharmaceuticals, Inc.'s (SGYP): Reviewing Hot Stock of Yesterday - Hot Stocks Point (NASDAQ:SGYP) - August 25 at 12:31 PM


Synergy Pharmaceuticals (NASDAQ:SGYP) Chart for Tuesday, October, 25, 2016

Last Updated on 10/25/2016 by Staff